Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network

Objective: To describe the role of biotechnological therapies in patients with tumor necrosis factor receptor associated periodic syndrome (TRAPS) and to identify any predictor of complete response. Methods: Clinical, laboratory, and therapeutic data from 44 Caucasian TRAPS patients treated with bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Antonio, Obici, Laura, Cattalini, Marco, Lopalco, Giuseppe, Merlini, Giampaolo, Ricco, Nicola, Soriano, Alessandra, La Torre, Francesco, Verrecchia, Elena, Insalaco, Antonella, Dagna, Lorenzo, Jaber, Masen Abdel, Montin, Davide, Emmi, Giacomo, Ciarcia, Luisa, Barneschi, Sara, Parronchi, Paola, Ruscitti, Piero, Maggio, Maria Cristina, Viapiana, Ombretta, Sota, Jurgen, Gaggiano, Carla, Giacomelli, Roberto, Sicignano, Ludovico Luca, Manna, Raffaele, Renieri, Alessandra, Lo Rizzo, Caterina, Frediani, Bruno, Rigante, Donato, Cantarini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295690/
https://www.ncbi.nlm.nih.gov/pubmed/34307404
http://dx.doi.org/10.3389/fmed.2021.668173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295690/
https://www.ncbi.nlm.nih.gov/pubmed/34307404
http://dx.doi.org/10.3389/fmed.2021.668173

Ejemplares similares